Akemi ARAKI

 I'm working on the 5th floor, looking at seasonal changes in the beautiful scenery.  Recently there has not been so big difference between the studying methods of each field in bioscience research, so I think it would be better to increase the exchange of information with each other.  Please feel free to drop in at our laboratory for a cup of coffee. Tasty coffee and delicious cakes are waiting for your coming.

Suzuki, K., Watanabe, T., Sakurai, S., Ohtake, K., Konoshita, T., Araki, A., Fujita, T., Takei, H., Takeda, Y., Sato, Y., Yamashita, T., Araki, Y., and Sendo, F. : Regulation of neutrophil extravasation by a novel glycosylphosphatidyl inositol (GPI)-anchored protein on leukocytes.  J. Immunol., 162, 4277-4284, 1999.

Uchida, T., Yamashita, T., Araki, A., Watanabe, H., and Sendo, F. : rIFN--activated rat neutrophils induce tumor cell apoptosis by nitric oxide.  Int. J. Cancer, 71, 231-236, 1997.

Yamashita, T., Uchida, T., Araki, A., and Sendo, F. : Nitric oxide is an effector molecule in inhibition of tumor cell growth by rIFN--activated rat neutrophils.  Int. J. Cancer, 71, 223-230, 1997.

Sato, T., Midorikawa, Y., Yamashita, T., Araki, A., and Sendo, F. : The neutrophil as an information transmitter in tumor inhibition by a streptococcal biological response modifier, OK-432.  Cancer Immunol. Immunother., 43, 77-86, 1996.

Araki, A., and Sedno, F. : Reduced anti-Pseudomonas Aeruginosa activity of a@cephalosporin, cefodizime, in rats whose neutrophils were selectively depleted by a monoclonal antibody.  Microbiol. Immunol., 40, 333-338, 1996.

Takei, H., Araki, A., Watanabe, H., Ichinose, A, and Sendo, F. : Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis.  J. Leukoc. Biol., 59, 229-240, 1996.

Kudo, C., Yamashita, T., Araki, A., Terashita, M., Watanabe, T., Atsumi, M., Tamura, M., and Sendo, F. : Modulation of the in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3.  I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats.  J. Immunol., 150, 3728-3738, 1993.

Kudo, C., Araki, A., Matsushima, K., and Sendo, F. : Inhibition of IL-8-induced W3/25+ (CD4+) T Iymphocyte recruitment into subcutaneous tissues of rats by selective depletion of in vivo neutrophils with a monoclonal antibody.  J. Immunol., 147, 2196-2201, 1991.

Araki, A., Inoue, T., Cragoe, E. J. Jr., and Sendo, F. : Na+/H+ exchange modulates rat neutrophil mediated tumor cytotoxicity.  Cancer Res., 51, 3212-3216, 1991.

Araki, A., Inoue, T., Kimura, S., Fukase, S., and Sendo, F. : Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).  Jpn. J. Cancer Res., 81, 69-78, 1990.

Inoue, T., Hamuro, J., Yoshimoto, R., Okano, A., Shitara, A., Arai, S., and Sendo, F. : A Tcell leukemia line produces factor(s) that render rat neutrophils cytotoxic.  Jpn. J. Cancer Res., 77, 693-702, 1986.